Algorithmovigilance, lessons from pharmacovigilance

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Algorithmovigilance, lessons from pharmacovigilance ; volume:7 ; number:1 ; day:2 ; month:10 ; year:2024 ; pages:1-6 ; date:12.2024
npj digital medicine ; 7, Heft 1 (2.10.2024), 1-6, 12.2024

Classification: Soziale Probleme, Sozialdienste, Versicherungen

Creator: Balendran, Alan
Benchoufi, Mehdi
Evgeniou, Theodoros
Ravaud, Philippe

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41746-024-01237-y

URN: urn:nbn:de:101:1-2412192101138.658863887679

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:37 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Balendran, Alan
Benchoufi, Mehdi
Evgeniou, Theodoros
Ravaud, Philippe
SpringerLink (Online service)

Other Objects (12)

Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR

Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology

Pharmacovigilance in oncology

Challenges and lessons learned from four years of planning and implementing pharmacovigilance enhancement in sub-Saharan Africa

Lessons from enriching Tanzania’s clinical research ethics clinical trials oversight and pharmacovigilance through the ASCEND project

Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance

Pharmacovigilance practice among pediatric neurologists from Poland and Germany

Chances and challenges of registry-based pharmacovigilance in multiple sclerosis: lessons learnt from the implementation of the multicenter REGIMS registry

Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study

Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry

Pharmacoenvironmentology – a component of pharmacovigilance

Towards robust pharmacovigilance surveillance systems

Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR

Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology

Pharmacovigilance in oncology

Challenges and lessons learned from four years of planning and implementing pharmacovigilance enhancement in sub-Saharan Africa

Lessons from enriching Tanzania’s clinical research ethics clinical trials oversight and pharmacovigilance through the ASCEND project

Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance

Pharmacovigilance practice among pediatric neurologists from Poland and Germany

Chances and challenges of registry-based pharmacovigilance in multiple sclerosis: lessons learnt from the implementation of the multicenter REGIMS registry

Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study

Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry

Pharmacoenvironmentology – a component of pharmacovigilance

Towards robust pharmacovigilance surveillance systems

Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR

Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology

Pharmacovigilance in oncology

Challenges and lessons learned from four years of planning and implementing pharmacovigilance enhancement in sub-Saharan Africa

Lessons from enriching Tanzania’s clinical research ethics clinical trials oversight and pharmacovigilance through the ASCEND project

Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance

Pharmacovigilance practice among pediatric neurologists from Poland and Germany

Chances and challenges of registry-based pharmacovigilance in multiple sclerosis: lessons learnt from the implementation of the multicenter REGIMS registry

Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study

Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry

Pharmacoenvironmentology – a component of pharmacovigilance

Towards robust pharmacovigilance surveillance systems

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Algorithmovigilance, lessons from pharmacovigilance

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR

Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology

Pharmacovigilance in oncology

Challenges and lessons learned from four years of planning and implementing pharmacovigilance enhancement in sub-Saharan Africa

Lessons from enriching Tanzania’s clinical research ethics clinical trials oversight and pharmacovigilance through the ASCEND project

Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance

Pharmacovigilance practice among pediatric neurologists from Poland and Germany

Chances and challenges of registry-based pharmacovigilance in multiple sclerosis: lessons learnt from the implementation of the multicenter REGIMS registry

Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study

Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry

Pharmacoenvironmentology – a component of pharmacovigilance

Towards robust pharmacovigilance surveillance systems

Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR

Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology

Pharmacovigilance in oncology

Challenges and lessons learned from four years of planning and implementing pharmacovigilance enhancement in sub-Saharan Africa

Lessons from enriching Tanzania’s clinical research ethics clinical trials oversight and pharmacovigilance through the ASCEND project

Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance

Pharmacovigilance practice among pediatric neurologists from Poland and Germany

Chances and challenges of registry-based pharmacovigilance in multiple sclerosis: lessons learnt from the implementation of the multicenter REGIMS registry

Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study

Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry

Pharmacoenvironmentology – a component of pharmacovigilance

Towards robust pharmacovigilance surveillance systems

Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR

Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology

Pharmacovigilance in oncology

Challenges and lessons learned from four years of planning and implementing pharmacovigilance enhancement in sub-Saharan Africa

Lessons from enriching Tanzania’s clinical research ethics clinical trials oversight and pharmacovigilance through the ASCEND project

Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance

Pharmacovigilance practice among pediatric neurologists from Poland and Germany

Chances and challenges of registry-based pharmacovigilance in multiple sclerosis: lessons learnt from the implementation of the multicenter REGIMS registry

Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study

Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry

Pharmacoenvironmentology – a component of pharmacovigilance

Towards robust pharmacovigilance surveillance systems

Related objects

Reset password